Linnelle Veldhouse
Internal Medicine · Wyoming, MINPI 1366679961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 32.9% of the total. 2025 is the largest year on record at $1,211, more than ten times the $39 reported in 2019.
Across 139 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$855
- AstraZeneca$357
- Amgen$273
- Bayer$177
- Pfizer$122
- Merck$106
- plus $707 from 16 others
What the payments were for
- Food & beverage$2,597100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $855 |
| AstraZeneca | 17 | $357 |
| Amgen | 13 | $273 |
| Bayer | 9 | $177 |
| Pfizer | 6 | $122 |
| Merck | 5 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $101 |
| Esperion Therapeutics, Inc. | 6 | $97 |
| GSK | 6 | $97 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Dexcom, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| AbbVie | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Antares Pharma, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
How this compares
$2,597 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $160 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Wyoming
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
- Mohamad HatahetWaterford$352K
- A FendrickAnn Arbor$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.